VENTURE LOAN AND SECURITY AGREEMENTVenture Loan and Security Agreement • August 29th, 2014 • Inotek Pharmaceuticals Corp • Pharmaceutical preparations • New York
LEASE Landlord: Farley White Kilnbrook Three, LLC Tenant: Inotek Pharmaceuticals Corporation Date of Lease: May 11th, 2012Lease • August 29th, 2014 • Inotek Pharmaceuticals Corp • Pharmaceutical preparations
Re: Employment AgreementEmployment Agreement • August 29th, 2014 • Inotek Pharmaceuticals Corp • Pharmaceutical preparations • Massachusetts
On behalf of Inotek Pharmaceuticals Corporation, a Delaware corporation (the “Company”), I am pleased to offer you the position of the Company’s President and Chief Executive Officer (“CEO”). The terms of your employment are set forth below.
INOTEK PHARMACEUTICALS CORPORATION AMENDMENT NO. 1 TO THE THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENTStockholders Agreement • August 29th, 2014 • Inotek Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
This Amendment No. 1 to the Third Amended and Restated Stockholders Agreement, dated as of June 11, 2010 (this “Amendment”), is entered into by and among Inotek Pharmaceuticals Corporation, a Delaware corporation (the “Company”), and the entities and individuals listed on the signature pages hereto. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Stockholders Agreement (as defined below).
THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENTStockholders Agreement • August 29th, 2014 • Inotek Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
STOCKHOLDERS AGREEMENT made this 9th day of June, 2010 by and among (i) Inotek Pharmaceuticals Corporation, a Delaware corporation (the “Company”), (ii) holders of Common Stock or options to acquire Common Stock or of Series X Convertible Preferred Stock (as defined below) whose names are set forth under the heading “Holders” on Schedule I hereto and each person who shall, after the date hereof, acquire shares of Common Stock or Series X Convertible Preferred Stock and join in and become a party to this Agreement by executing and delivering to the Company an Instrument of Accession in the form of Schedule II hereto (the persons described in this clause (ii) are referred to herein collectively as the “Holders” and singularly as a “Holder”) and (iii) those persons whose names are set forth under the heading “Investors” on Schedule I hereto and each person who shall, after the date hereof, acquire shares of Series AA Convertible Preferred Stock (as defined below) and join in and become a
